Understanding Critical Care Research: don't be fooled again

Professor Simon Finfer

Click here to access Forum Lectures list

Your first lecture is FREE

Lecture overview

The practice of medicine and healthcare, in general, is a fusion of art and science. The art of medicine relies on often intangible and unquantifiable components such as common sense and experience. The science of medicine arises from the conduct and interpretation of research which should be scientifically valid, quantifiable and applicable to the patient in front of you. Unfortunately, much research is poorly conducted, poorly analysed, poorly presented, and often interpreted by researchers who have a vested interest in the results. Understanding the ever-expanding methods used in clinical research in general, and particularly in critical care is essential to providing your patients with the best and most appropriate care. Fortunately, a structured approach to evaluating research evidence is possible and forms the basis of this talk. Adopting such an approach will allow you to provide better care and outcomes to your patients.

Learning Objectives:
By the end of this lecture, the attendee will be able to:

  1. Understand the different study methods used in critical care.
  2. Appreciate the strengths and weaknesses of different research methods.
  3. Discuss appropriate methods of analysis.
  4. Understand when study results should or should not affect your practice. 

This lecture is equal to 1 CE Contact Hour, 1 CPD Point, and 1 AMA PRA Category 1 Credit


Additional CME Info

Release Date: February 1, 2020, Termination Date: January 31, 2023

Accreditation: This activity has been planned and implemented in accordance with the accreditation requirements and policies of the Accreditation Council for Continuing Medical Education (ACCME) through the joint providership of EB Medicine and Continulus. EB Medicine is accredited by the ACCME to provide continuing medical education for physicians.

Credit Designation: EB Medicine designates this internet enduring material for a maximum of 1 AMA PRA Category 1 Credit™ per lecture. Physicians should claim only the credit commensurate with the extent of their participation in the activity. 

Commercial Support: This activity received no commercial support.

Earning Credit: In order to earn CME credit, the participant must take the pre-test, listen to the lecture, take the CME post-test, and complete the post-test evaluation.

Duration 1 hour(s).

Lecture speaker

Professor Simon Finfer

Professor Simon Finfer is a critical care physician and researcher in Sydney. He is an Adjunct Professor at the University of New South Wales and Chair of Critical Care in the School of Public Health at Imperial College London. He is past-Chair of the Australian and New Zealand Intensive Care Society (ANZICS) Clinical Trials Group. He chaired the Council of the International Sepsis Forum and is a member of the Global Sepsis Alliance Executive Board. Prof. Finfer’s major research interest is the design and conduct of large scale randomised controlled trial in critical care. Prof. Finfer is an Editor of The Oxford Textbook of Critical Care, the Critical Care Section Editor for The Oxford Textbook of Medicine and was a guest editor for The New England Journal of Medicine from 2012-2014. 

In 2020 Prof. Finfer was made an Officer (AO) in the Order of Australia for distinguished service to Intensive Care Medicine.


CME Faculty Disclosure: It is the policy of EB Medicine to ensure objectivity, balance, independence, transparency, and scientific rigor in all CME-sponsored educational activities. All faculty participating in the planning or implementation of a sponsored activity are expected to disclose to the audience any relevant financial relationships and to assist in resolving any conflict of interest that may arise from the relationship. In compliance with all ACCME Essentials, Standards, and Guidelines, all faculty for this CME activity were asked to complete a full disclosure statement. The speaker did not report any relevant financial interest or other relationship with the manufacturer(s) of any commercial product(s) discussed in this educational presentation.